EGFR mutations predict survival benefit from gefitinib in patients with advanced lung adenocarcinoma: a historical comparison of patients treated before and after gefitinib approval in Japan (Q46365337)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | EGFR mutations predict survival benefit from gefitinib in patients with advanced lung adenocarcinoma: a historical comparison of patients treated before and after gefitinib approval in Japan |
scientific article |
Statements
1 reference
EGFR mutations predict survival benefit from gefitinib in patients with advanced lung adenocarcinoma: a historical comparison of patients treated before and after gefitinib approval in Japan (English)
1 reference
Toshimi Takano
1 reference
Tomoya Fukui
1 reference
Yuichiro Ohe
1 reference
Koji Tsuta
1 reference
Seiichiro Yamamoto
1 reference
Hiroshi Nokihara
1 reference
Noboru Yamamoto
1 reference
Ikuo Sekine
1 reference
Hideo Kunitoh
1 reference
Koh Furuta
1 reference
Tomohide Tamura
1 reference
15 September 2008
1 reference
1 reference
26
1 reference
34
1 reference
5589-5595
1 reference
Identifiers
1 reference
1 reference